Ospedale S. Eugenio, ASL Roma 2

Roma 11 trials 6 recruiting

11 Registered trials

6 Currently recruiting

Organisation

Ospedale S. Eugenio, ASL Roma 2

Location

Roma, Italy

Identifier

ORL-000005305

Address

P.le dell'Umanesimo, 10, 00144, Italy

Departments

DIPARTIMENTO DELLE SPECIALITÀ
DIPARTIMENTO DELLE SPECIALITÀ - UOC EMATOLOGIA
Ematologia
IT30015:UOC Ematologia

Clinical trials at this site (11)

Search interface

Eltrombopag for the treatment of thrombocytopenia due to low - and intermediate risk myelodysplastic syndromes. Recruiting

2024-520133-72-00 Myelodysplastic syndromes 4 2025-02-05
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to Myelodysplastic Syndromes with del5q refractory/resistant/intolerant … Recruiting

2024-519310-31-00 Anemia due to MDS with del5q with IPSS-R very low, low, 4 2025-01-27
First-line combination of Bcl-2 inhibitor and monoclonal antibody followed by administration of Bcl-2 inhibitor alone or combination of Bcl-… Recruiting

2023-510431-11-00 Chronic Lymphocytic Leukemia 4 2023-07-21
The study is aimed at evaluating the feasibility of a hypomethylating treatment combined with hematopoietic stem cell transplantation in com… Recruiting

2023-510515-19-00 Higher-risk-myelodysplastic syndromes 5 2020-11-27
Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting

2023-510433-29-00 Favorable-intermediate-risk Acute Myeloid Leukemia 5 2020-09-24
Trial aimed at examinate the functionality and effectiveness of the drug "IO" in adult patients with a rare form of cancer that affect the c… Recruiting

2023-510516-39-00 Acute B-cell Lymphoblastic Leukemia with minimal residu 4 2019-10-30
Study aimed at evaluating the efficacy of the combination of the two drugs, Venetoclax and Azacitidine, on the treatment of patients sufferi… Ended

2023-510432-36-00 Acute Myeloid Leukemia with NPM1 mutation 4 2022-03-01
The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended

2023-508968-30-00 Adult Philadelphia Chromosome-Positive Acute Lymphoblas 5 2021-09-08
The aim of the study is to evaluate the efficacy of Ponatinib, either alone or in combination with chemotherapy, in inducing remission in pa… Ended

2024-516868-28-00 Ph+ Acute Lymphoblastic Leukemia 4 2021-05-04
A study comparing current available therapies with imetelstat for the treatment of intermediate-2 or high-risk MF who are not responding to … Ended

2023-509120-17-00 Myelofibrosis 5 2021-04-12
Sustained treatment-free period in the course of a disease when symptoms become less severe in BCR-ABL+ chronic myeloid leukemia: a prospect… Ended

2023-510434-83-00 Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) 6 2016-10-17